Alcohol Use Disorders in Schizophrenia
Treatment of Alcohol Use Disorders in Schizophrenia
1 other identifier
interventional
54
1 country
4
Brief Summary
The purpose of the study is to evaluate a new treatment to help patients who have problems because of their use of alcohol. The treatment is called Behavioral Treatment for Alcohol Abuse in Schizophrenia (BTAAS).We are interested in determining whether BTAAS is more effective in reducing use than a supportive control treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Mar 2004
Typical duration for not_applicable schizophrenia
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2004
CompletedFirst Submitted
Initial submission to the registry
January 19, 2006
CompletedFirst Posted
Study publicly available on registry
January 23, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2007
CompletedApril 6, 2020
April 1, 2020
3.2 years
January 19, 2006
April 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Symptom ratings, addiction severity, quality of life, social functioning & motivation to change: baseline and post-treatment.
1 year
Secondary Outcomes (1)
Saliva test & Urinalysis: baseline, post-treatment and at each treatment session.
1 year
Study Arms (1)
Supportive Treatment in Alcohol Recovery (STAR)
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- DSM-IV diagnosis of schizophrenia or schizoaffective disorder OR other severe disorder including bipolar disorder, major depression, or severe anxiety disorder (by definition, the patient has worked 25% or less of the past year; and/or the patient received payment for mental disability)
- Current (last month) Alcohol Abuse or Dependence or Alcohol Abuse or Dependence criteria met within the last 3 months as determined by the Structured Clinical Interview for DSM-IV.
- Ability to provide informed consent
- Stable housing
You may not qualify if:
- Current neurological disorder or cognitive impairment due to head injury or loss of consciousness that would impact ability to effectively participate in the intervention
- Mental retardation as indicated by chart review
- inability to effectively participate in the baseline assessments due to intoxication or psychiatric symptoms on two successive appointments
- patient is homeless.
- Inability to attend scheduled treatment sessions on a regular basis for any reason, or to appropriately participate in research activities due to behavioral or psychiatric problems.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Healthcare for the Homeless
Baltimore, Maryland, 21201, United States
University of Maryland, Baltimore
Baltimore, Maryland, 21201, United States
VA Maryland Healthcare System
Baltimore, Maryland, 21201, United States
Mosaic Community Services Inc.
Catonsville, Maryland, 21228, United States
Related Publications (6)
Bellack AS, DiClemente CC. Treating substance abuse among patients with schizophrenia. Psychiatr Serv. 1999 Jan;50(1):75-80. doi: 10.1176/ps.50.1.75.
PMID: 9890583BACKGROUNDBellack AS, Gearon JS. Substance abuse treatment for people with schizophrenia. Addict Behav. 1998 Nov-Dec;23(6):749-66. doi: 10.1016/s0306-4603(98)00066-5.
PMID: 9801714BACKGROUNDBennett ME. Interrelationship of substance abuse and mental health problems. In Miller WR & Weisner C (Eds.), Changing substance abuse through health and social systems. New York: Kluwer/Plenum, 2003.
BACKGROUNDBennett ME, Barnett, B.Adult psychopathology and diagnosis: Dual-diagnosis. In M. Hersen & SM Turner (Eds), Adult psychopathology and diagnosis, fourth edition. NY: Kluwer/Plenum, 2003.
BACKGROUNDBennett ME, Bellack AS, Gearon JS. Treating substance abuse in schizophrenia. An initial report. J Subst Abuse Treat. 2001 Mar;20(2):163-75. doi: 10.1016/s0740-5472(00)00167-7.
PMID: 11306219BACKGROUNDMiller WR, Andrews, NA, Wilbourne P, Bennett ME (1998). A wealth of alternatives: Effective treatments for alcohol problems. In Miller WR and Healther N. (Eds.). Treating addicting behaviors, second edition. NY: Plenum Press, 1998.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melanie Bennett, Ph.D.
University of Maryland, Baltimore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 19, 2006
First Posted
January 23, 2006
Study Start
March 1, 2004
Primary Completion
May 1, 2007
Study Completion
May 1, 2007
Last Updated
April 6, 2020
Record last verified: 2020-04